Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization.
about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesThe dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityPosttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replicationRNA-based mechanisms regulating host-virus interactionsAPOBEC3G: an intracellular centurionTemporal regulation of Ig gene diversification revealed by single-cell imaging.Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.Inducible APOBEC3G-Vif double stable cell line as a high-throughput screening platform to identify antiviral compounds.Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryLeveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNAAntiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granulesPopulation level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3HHuman immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variantProduction of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypesRegulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm VifAdvances in the structural understanding of Vif proteinsSmall-molecule inhibition of HIV-1 Vif.Cellular microRNA and P bodies modulate host-HIV-1 interactions.APOBEC3G complexes decrease human immunodeficiency virus type 1 production.Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.CBFß and HIV Infection.Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe.Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot trafficIdentification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
P2860
Q21090536-97DB58A7-45F9-4CA6-805E-EF1A4B861734Q21245195-9A7C4A1B-A25F-4327-8DBD-498685A58AFFQ24619114-24150188-F7FA-444A-B381-7118E6A25A30Q24647833-C75F7020-8B1E-47D3-92A6-1CCB4F17345BQ24672416-F2AC5B4B-F716-4316-BC34-D2EAE1BDDA9CQ28288234-F2023C2D-2FDA-4344-835B-15B7C1A4A696Q28754989-9F213644-4DC0-4242-A43F-7130BB038E6AQ30436370-EDBAED3C-B07E-4EA6-A58D-B0BC74CC19BBQ30483676-0AB0B536-BE6E-41D3-92D2-5FCEF3C3146EQ33511412-F3A2D78C-D4E7-44C5-9952-3F12E38A70C4Q33567848-EB844AD9-44B8-4554-9BFB-986D2D2DC402Q33654949-54C030FA-1358-4114-AB76-E13EBA8F68F6Q33999971-A9E888BC-3F5E-4D29-BABD-B188C8B83436Q34026341-1EBF2D62-C1A4-4956-9C4F-CC9C158C51A0Q34590679-B76FDB01-1815-459D-8740-9E8675FBDBB6Q35024235-2EDCD192-4BC4-4A0E-B88F-D0DC0F6F7D66Q35451347-7CCF396F-B0B4-4A0A-95C4-E3DD9D164C35Q35666084-4BB47C34-4712-4127-A74B-EC93A2BBAC15Q35947586-65ED18BE-7FC1-47F4-A091-1FE56F033D65Q36249419-85C3BD2D-F86D-4C9B-BAED-9B297CC01C97Q36366147-D9381B60-B799-4EFD-8B70-B1BDE758B7FDQ36677709-5D57604C-BC3F-4E6A-A2CF-3E15162107D1Q36827236-37EC4EC7-8802-49E5-BFAD-D2C5BC0E6115Q37047737-CCF972A9-92E7-46F4-AE9D-C674F6839AF9Q37099703-2BBDB0A8-9D41-492F-BE4A-7EB13AEC232FQ37108363-FB439D45-A246-460F-98BD-680E7BD6CDCEQ37218625-C0BCA21B-9D17-4413-8EBC-128145E1CC8BQ37391014-9AFD8522-DCC9-4FB5-8D33-FA503AED96DBQ38286147-DA4D7830-37D2-4F5E-A4BB-A3A53A5D9F2CQ38613375-092D84B6-5C91-4792-A60B-7CE45C135B1EQ38746224-08E992B1-6624-4017-A932-D076B57E12CEQ39181425-10B15FBF-F3B7-4909-8FE9-519EFEDE7462Q39966083-70B270FF-7923-47E0-82E4-93B6A9DA65AAQ40029354-CD73F7F7-FC2D-4358-8DA7-E39795B48361Q40161999-511C40E5-C4F5-49A2-A339-BF3CA2757E46Q40751332-F138D09A-137F-49D6-8D77-C09684C7D94DQ41450212-F5A3970F-C873-4FA2-9C92-34F985151B40Q41892602-78EAE44F-EB47-4489-902D-6DC5E68031F8Q42861821-E961AE61-BA6E-45E8-9AF9-8991375C2217Q42910736-C258CD66-6DCE-4711-A75E-E5C9772B643B
P2860
Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Analysis of HIV-1 viral infect ...... and subcellular localization.
@en
type
label
Analysis of HIV-1 viral infect ...... and subcellular localization.
@en
prefLabel
Analysis of HIV-1 viral infect ...... and subcellular localization.
@en
P2093
P2860
P356
P1476
Analysis of HIV-1 viral infect ...... and subcellular localization.
@en
P2093
Kozi Ichiyama
Michael J Wichroski
Tariq M Rana
P2860
P304
P356
10.1074/JBC.M408048200
P407
P577
2004-11-10T00:00:00Z